OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prognostic and predictive role of a metabolic rate‐limiting enzyme signature in hepatocellular carcinoma
Zhangding Wang, Yao Fu, Anliang Xia, et al.
Cell Proliferation (2021) Vol. 54, Iss. 10
Open Access | Times Cited: 13
Zhangding Wang, Yao Fu, Anliang Xia, et al.
Cell Proliferation (2021) Vol. 54, Iss. 10
Open Access | Times Cited: 13
Showing 13 citing articles:
Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies
Erbao Chen, Zhilin Zou, Rongyue Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Erbao Chen, Zhilin Zou, Rongyue Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Hypoxia Stimulates PYGB Enzymatic Activity to Promote Glycogen Metabolism and Cholangiocarcinoma Progression
Yani Pan, Yue Zhou, Yonghua Shen, et al.
Cancer Research (2024) Vol. 84, Iss. 22, pp. 3803-3817
Closed Access | Times Cited: 4
Yani Pan, Yue Zhou, Yonghua Shen, et al.
Cancer Research (2024) Vol. 84, Iss. 22, pp. 3803-3817
Closed Access | Times Cited: 4
Combining bulk and single-cell RNA-sequencing data to develop an NK cell-related prognostic signature for hepatocellular carcinoma based on an integrated machine learning framework
Qian Feng, Zhihao Huang, Lei Song, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 10
Qian Feng, Zhihao Huang, Lei Song, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 10
Metformin upregulates circadian gene PER2 to inhibit growth and enhance the sensitivity of glioblastoma cell lines to radiotherapy via SIRT2/G6PD pathway
Hai-Liang Li, Zheng Feei, Yang Wanfu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Hai-Liang Li, Zheng Feei, Yang Wanfu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Construction and validation of a prognostic model for hepatocellular carcinoma: Inflammatory ferroptosis and mitochondrial metabolism indicate a poor prognosis
Fang Han, Dan Cao, Xin Zhu, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 7
Fang Han, Dan Cao, Xin Zhu, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 7
Prognostic and Immunological Potential of Ribonucleotide Reductase Subunits in Liver Cancer
Xin Yin, Kan Jiang, Ziyang Zhou, et al.
Oxidative Medicine and Cellular Longevity (2023) Vol. 2023, pp. 1-14
Open Access | Times Cited: 5
Xin Yin, Kan Jiang, Ziyang Zhou, et al.
Oxidative Medicine and Cellular Longevity (2023) Vol. 2023, pp. 1-14
Open Access | Times Cited: 5
Metabolism-related signatures is correlated with poor prognosis and immune infiltration in hepatocellular carcinoma via multi-omics analysis and basic experiments
Jiapei Shen, Weijie Sun, Jiaying Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Jiapei Shen, Weijie Sun, Jiaying Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Withaferin A suppressed hepatocellular carcinoma progression through inducing IGF2BP3/FOXO1/JAK2/STAT3 pathway-mediated ROS production
Jinhai Li, Mengchen Ge, Pengcheng Deng, et al.
Immunopharmacology and Immunotoxicology (2023) Vol. 46, Iss. 1, pp. 40-48
Closed Access | Times Cited: 4
Jinhai Li, Mengchen Ge, Pengcheng Deng, et al.
Immunopharmacology and Immunotoxicology (2023) Vol. 46, Iss. 1, pp. 40-48
Closed Access | Times Cited: 4
A T-cell-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma based on transcriptomics and single-cell sequencing
Xu Chen, Chuang Peng, Yu Chen, et al.
BMC Bioinformatics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Xu Chen, Chuang Peng, Yu Chen, et al.
BMC Bioinformatics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Construction of endothelial cell‐related and autophagy‐related prognostic models for hepatocellular carcinoma based on single‐cell data
Lisha Mou, Kang Li, Chenyang Xu, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 5, pp. 809-820
Closed Access | Times Cited: 1
Lisha Mou, Kang Li, Chenyang Xu, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 5, pp. 809-820
Closed Access | Times Cited: 1
A glutamine metabolish-associated prognostic model to predict prognosis and therapeutic responses of hepatocellular carcinoma
Hao Xu, Hui‐Lin Pan, Fang Lian, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access
Hao Xu, Hui‐Lin Pan, Fang Lian, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access
High Expression of RRM1 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma
Guochao Mao, Changyou Shan, Weimiao Li, et al.
International Journal of General Medicine (2022) Vol. Volume 15, pp. 2607-2620
Open Access | Times Cited: 2
Guochao Mao, Changyou Shan, Weimiao Li, et al.
International Journal of General Medicine (2022) Vol. Volume 15, pp. 2607-2620
Open Access | Times Cited: 2
The pan-cancer analysis reveals FAM72D as a potential therapeutic target and closely linked to immune infiltration and prognosis in hepatocellular carcinoma
Guangzhen Qu, Dongming Li, Fei Xue, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Guangzhen Qu, Dongming Li, Fei Xue, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
